# Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

> **NCT02254278** · PHASE2 · COMPLETED · sponsor: **NRG Oncology** · enrollment: 316 (actual)

## Conditions studied

- Stage III Oropharyngeal Squamous Cell Carcinoma
- Stage IVA Oropharyngeal Squamous Cell Carcinoma
- Stage IVB Oropharyngeal Squamous Cell Carcinoma
- Stage IVC Oropharyngeal Squamous Cell Carcinoma
- Tongue Carcinoma

## Interventions

- **DRUG:** Cisplatin
- **RADIATION:** IMRT 6 weeks
- **RADIATION:** IMRT 5 weeks

## Key facts

- **NCT ID:** NCT02254278
- **Lead sponsor:** NRG Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2019-06-10
- **Final completion:** 2025-09-04
- **Target enrollment:** 316 (ACTUAL)
- **Last updated:** 2025-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02254278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02254278, "Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02254278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*